Antimicrobial Resistance News and Research

RSS

Murdoch University outlines research on antimicrobial resistance at symposium

Murdoch University profiled its strong teaching and research focus around a One Health agenda at a symposium on a looming public health issue, antimicrobial resistance (AMR), on December 8.

16 Dec 2014

ANTRUK welcomes first report on antibiotic resistance; becomes BIA’s 2015 charity

Professor Colin Garner, Chief Executive of Antibiotic Research UK (ANTRUK), the world’s first charity to tackle the impending health disaster of antibiotic resistance, welcomed the publication of the first report by the O’Neill Commission on antibiotic resistance.

14 Dec 2014

Janssen, USAID sign MOU to fight against health threat of antibiotic-resistant bacteria

Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP, has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development to step up the fight against the health threat of antibiotic-resistant bacteria.

12 Dec 2014

World-renowned experts to discuss challenges of antibiotic resistance at Murdoch University symposium

World-renowned experts in the fields of antibiotic resistance will come together at a symposium at Murdoch University to talk about an issue which has the potential to become one of the world’s biggest public health challenges.

4 Dec 2014

Antibiotic resistance: Theme for next Uppsala Health Summit

The theme for the next Uppsala Health Summit, to be held in Uppsala on 2-3 June 2015, is antibiotic resistance -- one of the biggest global health challenges of our day.

2 Dec 2014

MUHC study examines effect of regular re-evaluation of antibiotic use on cost, C. difficile infection rates

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre examined the effectiveness of adopting an antibiotic "time-out" during treatment, which involves regularly re-evaluating the treatment strategy as the clinical situation evolves.

18 Nov 2014

Experts focus on key issues impeding delivery of cardiac care in resource-limited settings

Critical care is defined by life-threatening conditions, which require close evaluation, monitoring, and treatment by appropriately trained health professionals. Cardiovascular care bears these same requirements.

14 Nov 2014

Representatives from 40 countries meet to discuss plan for antimicrobial resistance

Every year, 25,000 people die as a result of antimicrobial resistance in Europe. A global action plan against one of the greatest health threats of our time is the aim of a conference being held in Oslo on 13th-14th November.

14 Nov 2014

BioInfect 2014 conference explores global anti-microbial agenda

This year’s unique BioInfect conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry,was a major success.

10 Nov 2014

Liposomes can help prevent bacterial toxins from killing human cells

Published in Nature Biotechnology, the study at the University of Liverpool showed that specially engineered lipid (fat) bodies, called liposomes, can be used to prevent bacterial toxins from killing human cells.

7 Nov 2014

Experts to establish global anti-microbial agenda at 2014 BioInfect Conference

Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, is delighted to be hosting the 2014 BioInfect Conference. A major one day conference looking at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance, will take place at the Alderley Park Conference Centre, Cheshire on the 4th November 2014.

16 Oct 2014

Survey finds prevalence of antimicrobial-drug use in U.S. hospitals

A one-day prevalence survey of 183 hospitals found that approximately 50 percent of hospitalized patients included in the survey were receiving antimicrobial drugs, and that about half of these patients were receiving 2 or more antimicrobial drugs, according to a study in the October 8 JAMA, a theme issue on infectious disease. Most antimicrobial use was for infection treatment.

8 Oct 2014

Virginia Tech professor wins Paul L. Busch Award for outstanding work in water quality research

Amy Pruden, professor of civil and environmental engineering at Virginia Tech, is the 2014 recipient of the Paul L. Busch Award, including a $100,000 research grant.

1 Oct 2014

Leading Cystic Fibrosis experts call for greater research on antibacterial resistance

World leading Cystic Fibrosis experts, from Queen's University Belfast, have called for greater research to address the major concern of antibacterial resistance.

29 Sep 2014

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

The Honourable Rona Ambrose, Minister of Health, committed to continued efforts to strengthen global health security at the Global Health Security Agenda (GHSA) meeting in Washington, DC.

27 Sep 2014

DNA sequencing may lead to greater care for patients with ventilator-associated pneumonia

A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia.

23 Sep 2014

Widespread use of unnecessary antibiotics drives up avoidable healthcare costs

The Centers for Disease Control and Prevention (CDC) and Premier, Inc. have released new research on the widespread use of unnecessary and duplicative antibiotics in U.S. hospitals, which could have led to an estimated $163 million in excess costs.

11 Sep 2014

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.

8 Sep 2014

Study identifies best course of treatment for endophthalmitis

The most common cause of endophthalmitis, a potentially blinding condition that can occur after eye trauma, eye surgery, and eye injections, are the well-known staphylococci ("staph") and streptococci ("strep") bacterial strains, according to a study published in the August issue of Ophthalmology and based on a review of 25 years of cases at New York Eye and Ear Infirmary of Mount Sinai (NYEE).

21 Aug 2014

MRSA and antibiotic resistance is a major health threat

Antibiotic resistance continues at an alarming rate with the indiscriminate overuse of antibiotics given to humans and animals.

13 Aug 2014